Recent Analyst Forecasts and Stock Ratings
Iovance Biotherapeutics, Inc. FAQ's
Iovance Biotherapeutics, Inc. has been rated by research analysts at Piper Sandler, UBS, Stifel Nicolaus, Robert W. Baird, JMP Securities, Goldman Sachs in the past 90 days.